Trial Profile

A phase II trial of HER 096 into evaluate efficacy, safety and tolerability in early-stage Parkinson's patients

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 11 Mar 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

19 Feb 2026 Accoridng to a Herantis Pharma media release, company intends to initiate the study as soon as the necessary preparations, including regulatory approvals and securing additional resources, are completed.
19 Feb 2026 Accoridng to a Herantis Pharma media release, company announced that it is leading a consortium that has been selected for, pending final negotiation, an EUR 8.0 million grant from the Horizon Europe 2025 Research and Innovation program.The consortium, which also includes multiple European university hospitals, will use the funding to support this study.
18 Nov 2025 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com